Cizzle Biotechnology (LON:CIZ) Issues Quarterly Earnings Results

Cizzle Biotechnology (LON:CIZ) issued its quarterly earnings results on Tuesday. The company reported GBX (0.17) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Trading Up 2.6%

LON CIZ opened at GBX 2.57 on Tuesday. Cizzle Biotechnology has a 1-year low of GBX 1.20 and a 1-year high of GBX 3.30. The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35. The stock has a 50-day moving average of GBX 2 and a 200-day moving average of GBX 1.71. The firm has a market cap of £10.17 million, a PE ratio of -15.09 and a beta of 0.51.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.